Differences Between Plasma and Cerebrospinal Fluid p-tau181 and p-tau231 in Early Alzheimer’s Disease

Current advances in plasma and cerebrospinal fluid biomarkers in Alzheimer's disease

(2021) Antoine Leuzy et al.   CURRENT OPINION IN NEUROLOGY

Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology

(2021) Nicholas J. Ashton et al.   ACTA NEUROPATHOLOGICA

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

(2021) Henrik Zetterberg et al.   Molecular Neurodegeneration

Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects

(2021) Joana B Pereira et al.   BRAIN

Plasma Neurofilament Light Chain Predicts Cognitive Progression in Prodromal and Clinical Dementia with Lewy Bodies

(2021) Andrea Pilotto et al.   JOURNAL OF ALZHEIMERS DISEASE

Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease

(2021) D. O. T. Alawode et al.   JOURNAL OF INTERNAL MEDICINE

Biomarkers for neurodegenerative diseases

(2021) Oskar Hansson   NATURE MEDICINE

A multicentre validation study of the diagnostic value of plasma neurofilament light

(2021) Nicholas J. Ashton et al.   Nature Communications

Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes

(2021) Michelle M. Mielke et al.   JAMA Neurology

Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia

(2020) Shorena Janelidze et al.   NATURE MEDICINE

Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration

(2020) Elisabeth H. Thijssen et al.   NATURE MEDICINE

Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

(2020) Thomas K Karikari et al.   LANCET NEUROLOGY

Research criteria for the diagnosis of prodromal dementia with Lewy bodies

(2020) Ian G. McKeith et al.   NEUROLOGY

Plasma phospho-tau181 in presymptomatic and symptomatic familial Alzheimer’s disease: a longitudinal cohort study

(2020) Antoinette O’Connor et al.   MOLECULAR PSYCHIATRY

Comparing progression biomarkers in clinical trials of early Alzheimer’s disease

(2020) Nicholas C. Cullen et al.   Annals of Clinical and Translational Neurology

Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative

(2020) Thomas K. Karikari et al.   MOLECULAR PSYCHIATRY

Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography

(2018) Michelle M. Mielke et al.   Alzheimers & Dementia

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

(2018) Clifford R. Jack et al.   Alzheimers & Dementia

Overlap between Frontotemporal Dementia and Alzheimer's Disease: Cerebrospinal Fluid Pattern and Neuroimaging Study

(2018) Alessandro Padovani et al.   JOURNAL OF ALZHEIMERS DISEASE

Diagnosis and management of dementia with Lewy bodies

(2017) Ian G. McKeith et al.   NEUROLOGY

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

(2011) Katya Rascovsky et al.   BRAIN

CSF Alzheimer's disease-like pattern in corticobasal syndrome: evidence for a distinct disorder

(2011) B. Borroni et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY